Needle Free Drug Delivery Devices Market Growth

Needle free Drug Delivery Devices Market Growth is Anticipated at CAGR of 5.8% by 2035; Patient Preference for Painless Drug Administration Will be the Key Market Driver

According to a recently published report by Roots Analysis, the growing preference of patients towards pain-free self-administration of vaccines and drugs and the ongoing technological advancements, including improvements in design, functionality and usability are driving the needle free drug delivery market.

Needle free Drug Delivery Devices Market Overview

The needle free drug delivery devices market size is estimated to be worth USD 2,720 million in 2024 and is expected to reach USD 5,031 million by 2035, growing at a CAGR of 5.8% during the forecast period till 2035.

In recent years, the pharmaceutical industry has witnessed technological advancements with the emergence of latest drug delivery devices, such as needle free systems, jet injectors, pen injectors and microneedle patches. It is worth highlighting that these devices have in-built safety mechanisms (which minimizes the risk of needlestick injuries) and include improvements in design, functionality and usability over conventional needles, thereby facilitating pain-free self-administration of vaccines and drugs across the dermis. Further, these devices are highly versatile, in terms of administering different types of drugs, including complex biologics, insulin, vaccines and other injectable medications. This has led a discernible shift in patient preferences towards painless drug administration, driving the increasing acceptance and adoption of these systems.

Browse 140+ figures and 170+ market data tables spread across 340+ pages and detailed Table of Content on “Needle free Drug Delivery Devices Market by Type of Device (Needle-free Injection System and Microneedle Devices), Route of Administration, Actuation Mechanism, Product Usability, Application Area, Type of Load, Product Type, Type of Microneedle Device, Type of Intervention and Geography” here: https://www.rootsanalysis.com/reports/microneedles-and-needle-free-injection-systems-jet-injectors-devices-/276.html

Market Drivers

Several factors are propelling the needle free drug delivery devices market growth. One of the key factors driving the future of needle free drug delivery devices market is the rising prevalence of chronic diseases. Further, there has been a fundamental shift towards self-administration devices, owing to the increased patient  convenience offered by such devices. It is worth mentioning that self-administration of drugs using needle free devices reduce healthcare costs (for patients as well as for the healthcare system) by moving treatment from hospitals to home settings. In addition, continuous innovation in needle-free technologies, including advancements in design, functionality, usability and features, such as needleless administration, improved dosing capabilities, is likely to promote the adoption of needle free devices.

Market Restraints

While the needle free devices market is experiencing substantial growth, there are certain restraints that can hinder the growth of this industry. One of the primary restraints in this domain is the high initial costs associated with the development of needle free devices. The injection systems designed to deliver medication without needles require advanced technology and precision engineering which contributes significantly to their higher upfront expenses. Further, some patients might encounter technical difficulties in operating the devices properly, potentially resulting in adverse effects. Moreover, while needle-free technologies excel in delivering medications through skin, their application for intravenous (IV) administration remains relatively underdeveloped, thereby limiting the adoption of these devices in critical care settings and intravenous therapies.

Growth Factors

Despite the aforementioned challenges, various factors continue to drive the needle free drug delivery devices market growth. One notable factor is the rising prominence of personalized medicines, boosting the demand for targeted drug delivery systems, such as microneedles. These devices are designed to deliver medications directly to specific sites within the body, offering precise dosage, leading to effective treatment. In addition, microneedle patches can be tailored to specific needs in order to accommodate different drug formulations and doses. This has led to representing a promising avenue for personalized drug delivery by combining precision, convenience, and enhanced therapeutic efficacy.

Needle free Drug Delivery Devices Market Segments

Based on product type, the market is segmented into fillable devices and prefilled devices

• The fillable devices segment is likely to capture the largest revenue share of 85% in the needle free drug delivery devices market, by 2024.
• The prefilled devices segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 4.4% during the forecast period.

Based on the actuation mechanism, the market is segmented into spring-based devices, compressed-gas devices and other devices

• The spring-based devices segment captures the largest revenue share of close to 65% in the needle free drug delivery devices market, by 2024.
• The compressed-gas devices segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 4.23% during the forecast period.

Based on the product usability, the market is segmented into reusable devices and disposable devices

• The reusable devices segment captures the largest revenue share of 60% in the needle free drug delivery devices market, by 2024.
• The reusable devices segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 4.2% during the forecast period.

Based on the type of load, the market is segmented into liquid-based devices, powder-based devices and projectile / depot-based devices

• The liquid-based devices segment captures the largest revenue share of over 55% in the needle free drug delivery devices market, by 2024.
• The liquid-based devices segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 4.1% during the forecast period.

Based on the route of administration, the market is segmented into subcutaneous route, intramuscular route and intradermal route

• The subcutaneous route segment captures the largest revenue share of 55% in the needle free drug delivery devices market, by 2024.
• The intramuscular route segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 4.23% during the forecast period.

Based on the application area, the market is segmented into insulin delivery, pain management, vaccination and dermatology

• The devices designed for insulin delivery captures the largest revenue share of  35% in the needle free drug delivery devices market, by 2024.
• The devices designed for vaccination is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 6.2% during the forecast period.

Based on geography, the market is segmented North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America

• North America is likely to dominate the needle free drug delivery devices market, by capturing the largest revenue share of nearly 40%, in 2024.
• In Middle East and North Africa, the needle free drug delivery devices market is likely to demonstrate considerable growth during the forecast period.

Based on the type of microneedle, the market is segmented hollow microneedles, solid microneedles, dissolving microneedles and coated microneedles

• The hollow microneedles segment captures the largest revenue share of nearly 40% in the needle free drug delivery devices market, by 2024.
• The solid microneedle devices segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 6.5% during the forecast period.

Based on the type of material, the market is segmented polymer microneedles, silicon microneedles, metal microneedles and ceramic microneedles

• The polymer microneedles segment captures the largest revenue share of nearly 35% in the needle free drug delivery devices market, by 2024.
• The polymer microneedle devices segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 6.6% during the forecast period.

Based on the type of interventions, the market is segmented into vaccines, therapeutic agents and other interventions

• The devices designed to administer vaccines capture the largest revenue share of 60% in the needle free drug delivery devices market, by 2024.
• The devices designed for administering therapeutic agents is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 6.5% during the forecast period.

Based on the application area, the market is segmented into insulin delivery, pain management, vaccination and oncology

• The devices designed for insulin delivery captures the largest revenue share of 45% in the needle free drug delivery devices market, by 2024.
• The devices designed for vaccination is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 8.8% during the forecast period.

Based on the Geography, the market is segmented North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America

• North America is likely to dominate the needle free drug delivery devices market, by capturing the largest revenue share of nearly 45%, in 2024.
• In Europe, the needle free drug delivery devices market is likely to demonstrate considerable growth (CAGR) of 7.2% during the forecast period.

Key Companies Profiled

The needle free drug delivery devices market report also includes profiles of key players (listed below) that provide needle free drug delivery devices:

• 3M
• Debiotech
• INCYTO
• Micropoint Technologies
• NanoPass Technologies
• Nemaura Pharma
• Theraject
• Antares Pharma
• D’Antonio Consultants International
• HNS International
• Injex
• INOVIO Pharmaceuticals
• Medical International Technology
• Mika Medical
• Pharmajet
• QS Medical Technology (Quinovare)
• Zogenix

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/microneedles-and-needle-free-injection-systems--jet-injectors-devices-/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com